Genenta Science S.p.A. (GNTA)
4.10
-0.13 (-3.07%)
At close: Jan 15, 2025, 3:58 PM
4.09
-0.24%
After-hours Jan 15, 2025, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -11.65M | -8.48M | -5.53M | -5.59M | -4.60M |
| Depreciation & Amortization | 42.45K | 6.14K | 4.89K | 1.90K | n/a |
| Stock-Based Compensation | 739.88K | 722.74K | 497.10K | 460.19K | 749.51K |
| Other Working Capital | 310.58K | -763.88K | -1.58M | -903.29K | 1.38M |
| Other Non-Cash Items | 75.69K | 90.36K | 13.23K | 6.06K | 4.87K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -417.60K | 240.30K | -1.94M | -920.72K | 1.35M |
| Operating Cash Flow | -11.21M | -7.42M | -6.96M | -6.04M | -2.49M |
| Capital Expenditures | -13.79K | -27.07K | -9.01K | -20.87K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -14.57M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -304.99K | -27.07M | -9.01M | n/a | n/a |
| Investing Cash Flow | -14.89M | -27.07K | -9.01K | -20.87K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 543.00 | -111.12K | -318.51K |
| Financial Cash Flow | 531.00 | n/a | 28.74M | 1.39M | 14.77M |
| Net Cash Flow | -26.10M | -7.45M | 21.77M | -4.68M | 12.28M |
| Free Cash Flow | -11.22M | -7.45M | -6.97M | -6.07M | -2.49M |